Arvinas (ARVN) News Today $6.61 -0.20 (-2.94%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARVN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Algert Global LLC Has $3.95 Million Stake in Arvinas, Inc. (NASDAQ:ARVN)Algert Global LLC lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 22.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 205,988 shares of the company's stock after acquiring an additional 37,927May 9 at 4:59 AM | marketbeat.comContrasting Arvinas (NASDAQ:ARVN) and Mustang Bio (NASDAQ:MBIO)May 9 at 1:53 AM | americanbankingnews.comCitigroup Cuts Arvinas (NASDAQ:ARVN) Price Target to $9.50Citigroup lowered their target price on shares of Arvinas from $10.00 to $9.50 and set a "neutral" rating for the company in a research note on Monday.May 7 at 6:21 PM | marketbeat.comBMO Capital Markets Issues Pessimistic Forecast for Arvinas (NASDAQ:ARVN) Stock PriceBMO Capital Markets dropped their price target on Arvinas from $20.00 to $10.00 and set an "outperform" rating on the stock in a research note on Monday.May 7 at 9:42 AM | marketbeat.comArvinas (NASDAQ:ARVN) Given "Hold" Rating at Truist FinancialTruist Financial restated a "hold" rating and issued a $11.00 target price on shares of Arvinas in a report on Monday.May 7 at 9:24 AM | marketbeat.comTruist Financial Reiterates Hold Rating for Arvinas (NASDAQ:ARVN)May 7 at 2:09 AM | americanbankingnews.comBMO Capital Markets Has Lowered Expectations for Arvinas (NASDAQ:ARVN) Stock PriceMay 7 at 2:09 AM | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), Design Therapeutics (DSGN) and Arvinas Holding Company (ARVN)May 6 at 5:55 PM | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. ...May 6 at 3:11 PM | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 6 at 2:04 PM | prnewswire.comTruist Securities Downgrades Arvinas (ARVN)May 6 at 5:39 AM | msn.comArvinas (NASDAQ:ARVN) Given New $9.50 Price Target at CitigroupMay 6 at 1:56 AM | americanbankingnews.comArvinas Holding Company (ARVN) Receives a Hold from WedbushMay 6 at 12:38 AM | theglobeandmail.comKirby McInerney LLP Announces Investigation of Potential Claims Against Arvinas, Inc. (ARVN) on Behalf of InvestorsMay 5, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 5, 2025 | globenewswire.comArvinas, Inc. (NASDAQ:ARVN) Short Interest Up 21.0% in AprilArvinas, Inc. (NASDAQ:ARVN - Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 7,730,000 shares, a growth of 21.0% from the March 31st total of 6,390,000 shares. Based on an average trading volume of 2,260,000 shares, the days-to-cover ratio is currently 3.4 days. Currently, 11.9% of the shares of the company are sold short.May 5, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Posts Quarterly Earnings Results, Beats Estimates By $2.07 EPSArvinas (NASDAQ:ARVN - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.93) by $2.07. Arvinas had a negative return on equity of 33.75% and a negative net margin of 75.51%. The business's revenue was up 646.2% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.97) EPS.May 5, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Shares Bought by ArrowMark Colorado Holdings LLCArrowMark Colorado Holdings LLC grew its position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 42.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,776,555 shares of the company's stock after buying an additional 532,105 shaMay 5, 2025 | marketbeat.comArvinas' (ARVN) "Overweight" Rating Reiterated at Piper SandlerMay 5, 2025 | americanbankingnews.comBarclays Cuts Arvinas (NASDAQ:ARVN) Price Target to $16.00May 5, 2025 | americanbankingnews.comArvinas: Yet Another Biotech Trading Below Net Cash, But It's Only A Mild Bull CaseMay 4, 2025 | seekingalpha.comArvinas, Inc. Just Reported A Surprise Profit And Analysts Updated Their EstimatesMay 4, 2025 | finance.yahoo.comPiper Sandler Reiterates Overweight Rating for Arvinas (NASDAQ:ARVN)Piper Sandler reiterated an "overweight" rating and set a $14.00 price objective (down previously from $24.00) on shares of Arvinas in a research report on Friday.May 4, 2025 | marketbeat.comHC Wainwright Has Lowered Expectations for Arvinas (NASDAQ:ARVN) Stock PriceHC Wainwright reduced their price objective on shares of Arvinas from $81.00 to $24.00 and set a "buy" rating for the company in a research note on Friday.May 4, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Price Target Cut to $16.00 by Analysts at BarclaysBarclays lowered their price objective on shares of Arvinas from $32.00 to $16.00 and set an "overweight" rating on the stock in a research report on Friday.May 4, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Lowered to Hold Rating by TD CowenTD Cowen lowered Arvinas from a "buy" rating to a "hold" rating in a research report on Friday.May 4, 2025 | marketbeat.comJefferies Financial Group Reaffirms "Hold" Rating for Arvinas (NASDAQ:ARVN)Jefferies Financial Group reiterated a "hold" rating and issued a $10.00 price target (down from $52.00) on shares of Arvinas in a research note on Friday.May 4, 2025 | marketbeat.comBoxer Capital Management LLC Makes New Investment in Arvinas, Inc. (NASDAQ:ARVN)Boxer Capital Management LLC purchased a new stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,058,614 shares of the company's stock, valued at apMay 4, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Rating Lowered to "Hold" at TD CowenMay 4, 2025 | americanbankingnews.comHC Wainwright Cuts Arvinas (NASDAQ:ARVN) Price Target to $24.00May 4, 2025 | americanbankingnews.comArvinas (NASDAQ:ARVN) Sees Large Volume Increase After Strong EarningsMay 4, 2025 | americanbankingnews.comSchonfeld Strategic Advisors LLC Has $12.58 Million Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN)Schonfeld Strategic Advisors LLC grew its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 84.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 656,100 shares of the company's stock after purchasing anMay 3, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) have received an average recommendation of "Moderate Buy" from the sixteen ratings firms that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and eleven have issued a buy recomMay 3, 2025 | marketbeat.comJefferies Downgrades Arvinas (ARVN)May 2, 2025 | msn.comArvinas Shares Drop; Cancels Two Drug Trials With Pfizer Amid Capital Markets ChallengesMay 2, 2025 | marketwatch.comArvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...May 2, 2025 | finance.yahoo.comHere are 1 Main Capital Partners’ Views on Arvinas (ARVN)May 2, 2025 | finance.yahoo.comArvinas, Inc. (ARVN) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comBREAKING: Block & Leviton Investigating Arvinas, Inc. (ARVN) For Securities Fraud After Shares Fall Over 20%; Investors Encouraged to Contact the Firm to Potentially Recover LossesMay 1, 2025 | globenewswire.comArvinas stock tumbles following workforce reduction and trial removalsMay 1, 2025 | investing.comArvinas stock slides after eliminating trials, reducing workforceMay 1, 2025 | msn.comArvinas (ARVN) to Release Quarterly Earnings on TuesdayArvinas (NASDAQ:ARVN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-arvinas-inc-stock/)May 1, 2025 | marketbeat.comArvinas Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 1, 2025 | globenewswire.comArvinas Q1 2025 Earnings PreviewApril 30, 2025 | msn.comPrice T Rowe Associates Inc. MD Boosts Holdings in Arvinas, Inc. (NASDAQ:ARVN)Price T Rowe Associates Inc. MD lifted its holdings in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,103,011 shares of the company's stockApril 30, 2025 | marketbeat.comBarclays PLC Boosts Stake in Arvinas, Inc. (NASDAQ:ARVN)Barclays PLC raised its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 43.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 175,019 shares of the company's stock after buying an additional 53,320 shares during the period. Barclays PApril 30, 2025 | marketbeat.comRenaissance Technologies LLC Has $1.32 Million Stake in Arvinas, Inc. (NASDAQ:ARVN)Renaissance Technologies LLC reduced its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 52.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 68,900 shares of the company's stock after selling 75,500 shares durApril 30, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Takes $42.33 Million Position in Arvinas, Inc. (NASDAQ:ARVN)T. Rowe Price Investment Management Inc. purchased a new position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 2,208,234 shares of the company's stock, valued at approximately $42April 29, 2025 | marketbeat.comArvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025April 28, 2025 | globenewswire.comArvinas Shares New Preclinical Combination Data for the PROTAC BCL6 Degrader, ARV-393, at the 2025 American Association for Cancer Research Annual MeetingApril 28, 2025 | globenewswire.com Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address ARVN Media Mentions By Week ARVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARVN News Sentiment▼0.080.62▲Average Medical News Sentiment ARVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARVN Articles This Week▼417▲ARVN Articles Average Week Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NAMS News Today AAPG News Today KYMR News Today MIRM News Today CGON News Today TWST News Today KNSA News Today TARS News Today BEAM News Today BLTE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARVN) was last updated on 5/9/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredIt may already be too late… A global energy shift is underway—and lithium is at the center of it. From electric vehicles to grid storage a...Huge Alerts | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arvinas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arvinas With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARVN Stock Free ARVN Stock Alerts